New Abortion Pill Rules Challenge Catholics to Reimagine Effective Pro-Life Outreach

Just six months after the U.S. Supreme Court’s landmark Dobbs v. Jackson Women’s Health Organization decision that abortion is not a constitutional right, America’s pro-life advocates and health care providers are preparing for another consequential shift following the U.S. Food and Drug Administration’s finalization of a rule change that expands availability of the abortion pill mifepristone.